Print

COURSE INFORMATION
Course CodeCourse TitleL+P HourSemesterECTS
FRM 609ADVANCED CHEMOTHERAPY III: CANCER TREATMENT3 + 03rd Semester5

COURSE DESCRIPTION
Course Level Doctorate Degree
Course Type Elective
Course Objective Pharmacokinetics and pharmacodynamics of drug groups in cancer treatment
Course Content Cancer drug groups, pharmacokinetics of cancer drug groups, pharmacodynamics of cancer drug groups, polymorphisms affecting the pharmacokinetics of cancer drug groups, Polymorphisms of cancer drug groups in clinical practice, new cancer drugs and products under development.
Prerequisites No the prerequisite of lesson.
Corequisite No the corequisite of lesson.
Mode of Delivery Face to Face

COURSE LEARNING OUTCOMES
3Comprehending the pharmacological properties of drugs in cancer treatment.
2To understand the drugs used in cancer treatment considering their usage characteristics.

COURSE'S CONTRIBUTION TO PROGRAM
PO 01PO 02PO 03PO 04PO 05PO 06PO 07PO 08
LO 002        
LO 003        
Sub Total        
Contribution00000000

ECTS ALLOCATED BASED ON STUDENT WORKLOAD BY THE COURSE DESCRIPTION
ActivitiesQuantityDuration (Hour)Total Work Load (Hour)
Course Duration (14 weeks/theoric+practical)14342
Hours for off-the-classroom study (Pre-study, practice)22448
Final examination12020
Midterm12020
Total Work Load

ECTS Credit of the Course






130

5
COURSE DETAILS
 Select Year   


 Course TermNoInstructors
Details 2021-2022 Spring1ARZU YAREN
Details 2021-2022 Spring1OSMAN ÇİFTÇİ
Details 2021-2022 Fall1ARZU YAREN
Details 2021-2022 Fall1OSMAN ÇİFTÇİ


Print

Course Details
Course Code Course Title L+P Hour Course Code Language Of Instruction Course Semester
FRM 609 ADVANCED CHEMOTHERAPY III: CANCER TREATMENT 3 + 0 1 Turkish 2021-2022 Spring
Course Coordinator  E-Mail  Phone Number  Course Location Attendance
HSTN A1101-15 TIP C0104 TIP C0105 %
Goals Pharmacokinetics and pharmacodynamics of drug groups in cancer treatment
Content Cancer drug groups, pharmacokinetics of cancer drug groups, pharmacodynamics of cancer drug groups, polymorphisms affecting the pharmacokinetics of cancer drug groups, Polymorphisms of cancer drug groups in clinical practice, new cancer drugs and products under development.
Topics
Materials
Materials are not specified.
Resources
Course Assessment
Assesment MethodsPercentage (%)Assesment Methods Title
Final Exam50Final Exam
Midterm Exam50Midterm Exam
L+P: Lecture and Practice
PQ: Program Learning Outcomes
LO: Course Learning Outcomes